Vasopressin antagonist formulation and process

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/48 (2006.01) A61K 31/5513 (2006.01) A61K 31/5517 (2006.01)

Patent

CA 2388474

This invention provides novel formulations for N-[4-(5H-pyrrolo[2,1- c][1,4]benzodiazepin-10(11H)ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methyl- benzamide, or a pharmaceutically acceptable salt thereof, and processes for making them, the formulations comprising from about 1 % to about 20 % of active ingredient, from about 1 % to about 18 % of a surfactant component, from about 50 % to about 80 % of a component of one or more polyethylene glycols, from about 1 % to about 20 % of a component of one or more sucrose fatty acid esters and/or polyvinylpyrrolidone and, optionnaly, one or more pharmaceutically acceptable preservatives or antioxidants.

L'invention concerne de nouvelles formulations de N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazépin-10(11H)ylcarbonyl)-3-chlorophényl]-5-fluoro-2-méthyl-benzamide, ou leurs sels pharmaceutiquement acceptables, et leurs procédés de fabrication. Lesdites formulations comprennent environ 1 % à environ 20 % d'un ingrédient actif, environ 1 % à environ 18 % d'un composant tensio-actif, environ 50 % à environ 80 % d'un composant renfermant un ou plusieurs polyéthylèneglycols, environ 1 % à environ 20 % d'un composant renfermant un ou plusieurs esters d'acides gras de sucrose et/ou de polyvinylpyrrolidone et, éventuellement, un ou plusieurs conservateurs ou antioxydants pharmaceutiquement acceptables.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vasopressin antagonist formulation and process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vasopressin antagonist formulation and process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasopressin antagonist formulation and process will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1838651

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.